IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer
This study has been withdrawn prior to enrollment.
(company (Inovio) is no longer able to support the study)
Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Collaborators:
Inovio Pharmaceuticals
Centre Hospitalier Universitaire Vaudois
Information provided by (Responsible Party):
European Organisation for Research and Treatment of Cancer - EORTC
ClinicalTrials.gov Identifier:
NCT02501278
First received: July 7, 2015
Last updated: May 12, 2016
Last verified: May 2016
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Study Status: | This study has been withdrawn prior to enrollment. |
|---|---|
| Estimated Study Completion Date: | May 2021 |
| Estimated Primary Completion Date: | May 2019 (Final data collection date for primary outcome measure) |